CBIZ, Inc. (CBZ) AI Stock Analysis

CBIZ, Inc. delivers financial, insurance, and advisory services across the United States and Canada, operating primarily through three segments: Financial Services, Benefits and Insurance Services, and National Practices. Its Financial Services division provides accounting, tax preparation, financial advisory, valuation, risk management, and government healthcare consulting. The Benefits and Insurance Services unit offers employee benefits consulting, payroll, human capital management, property and casualty insurance, and retirement and investment services. The National Practices segment handles information technology managed networking, hardware, and healthcare consulting. CBIZ primarily serves small and medium-sized businesses, governmental entities, and not-for-profit organizations.

CBIZ expanded revenue from $1.10B in FY2021 to $2.76B in FY2025, achieving a 52.1% revenue increase in FY2025 alone. Net income rose from $70.9M in FY2021 to $115.4M in FY2025, while EPS increased from $1.64 to $3.55 over the same timeframe. Annual gross margin was 12.9% and operating margin was 8.5% in FY2025. For the trailing twelve months ended June 30, 2026, revenue stood at $2.77B with an operating margin of 5.0% and a profit margin of 4.4%. In the latest quarter, quarterly revenue fell 0.2% and quarterly earnings dropped 53.0% compared to the prior-year period.

As of June 30, 2026, CBIZ held $20.9M in cash and short-term investments against total debt of $1.91B, resulting in net debt of $1.89B. Shareholders' equity was $1.87B, with a debt-to-equity ratio of 1.02 and a current ratio of 1.47. In FY2025, operating cash flow reached $192.5M, supporting capital expenditures of $17.0M and generating free cash flow of $175.5M. The company directed $160.1M toward share buybacks during FY2025, while its share count grew 14.7% over the past 5 years.

CBIZ trades at a trailing P/E of 26.3x, above the 24.8x median of its US-listed Industrials peers, while its forward P/E of 12.2x is lower than the peer median of 17.2x. Its price-to-sales multiple is 1.1x versus the peer median of 1.5x, and EV/EBITDA is 13.2x compared to the peer median of 13.9x. The stock has gained 4.8% over the past year and 57.1% over five years, trailing the S&P 500 benchmark returns of 16.8% and 83.0% over the corresponding periods.

Wall Street coverage includes 3 Hold ratings, with no Buy or Sell recommendations. The mean price target is $55.00, representing a 0.4% premium over the last close of $54.78 on October 16, 2026. For the fiscal year ending December 31, 2026, analysts estimate EPS of $4.03, representing 11.5% growth, on revenue of $2.82B. For the following fiscal year, 4 analysts project EPS of $4.25 and revenue of $2.95B. CBIZ beat EPS estimates in 3 of the last 4 quarters, and its next earnings date is November 4, 2026.

This page is an AI-written research summary of CBIZ, Inc. (CBZ). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CBZ income statement, CBZ balance sheet, CBZ key metrics, CBZ analyst forecast, CBZ chart. See the CBZ stock overview for the latest quote and news.